Cedars Sinai Intellectual Property Co 4
4 · Prometheus Biosciences, Inc. · Filed Apr 5, 2022
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2022-04-05−142,376→ 4,866,132 total(indirect: See Footnote)
Footnotes (2)
- [F1]Represents the transfer of an aggregate total of 142,376 shares of the Issuer's common stock held by Cedars Sinai Intellectual Property Company (CSIPC) to three inventors of Cedars-Sinai Medical Center (CSMC) as compensation for their services.
- [F2]The securities reported herein are held directly by CSIPC, a wholly owned subsidiary of CSMC.